The Beatson Institute

Site:	The Beatson Institute	Go to their website
Address:	Garscube Estate Switchback Road Bearsden
City:	Glasgow
State:
Zip:	G61 1BD
Country:	UK

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Active, not recruiting	Active, not recruiting	Bezuclastinib plus Sunitinib	NCT05208047
1	Phase I (PH I) Mad Refractory Solid Tumor Study	Completed	Closed	Dasatinib (BMS-354825)	NCT00099606